CFA
AMRX icon

Carroll Financial Associates’s Amneal Pharmaceuticals AMRX Stock Holding History

Carroll Financial Associates’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-42
Closed – – 1514
2020
Q3 		$0 Hold
42
– – ﹤0.01% 1481
2020
Q2 		$0 Hold
42
– – ﹤0.01% 1503
2020
Q1 		$0 Hold
42
– – ﹤0.01% 1435
2019
Q4 		$0 Hold
42
– – ﹤0.01% 1520
2019
Q3 		$0 Sell
42
-3
-7% -$10 ﹤0.01% 1505
2019
Q2 		$0 Buy
45
+43
+2,150% +$440 ﹤0.01% 1561
2019
Q1 		$0 Buy
+2
New +$26 ﹤0.01% 1357

Other funds holding AMRX

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Carroll Financial Associates's AMRX Position: Q4 2020 in Review

Carroll Financial Associates sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 42 shares.

Carroll Financial Associates first reported a position in AMRX in Q1 2019 and held it in 7 quarters. The position peaked at $0 in Q3 2020. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

  • Carroll Financial Associates reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Carroll Financial Associates sold 42 Amneal Pharmaceuticals shares in Q4 2020.
  • Carroll Financial Associates first reported a position in Amneal Pharmaceuticals in Q1 2019 and held it in 7 quarters.
  • Carroll Financial Associates's Amneal Pharmaceuticals position peaked at $0 in Q3 2020.
  • 133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on Carroll Financial Associates's 13F filing for Q4 2020, filed 8 Jan 2021.